|
|
Science Sparks @ ACTREC
|
29th January 2024 |
Vol. No. 13 ; Issue No.615 |
|
Publications
|
1. Patwardhan RS, Gohil D, Singh B, Kumar BK, Purohit V, Thoh M, Checker R, Gardi N, Gota V, Kutala VK, Patwardhan S, Sharma D, Sandur SK (2024). Mitochondrial-targeted curcumin inhibits T-cell activation via Nrf2 and inhibits graft-versus-host-disease in a mouse model. Phytotherapy Research.
2. Noronha V, Patil V, Chaturvedi P, Mathrudev V, Menon N, Bhattacharjee A, Singh A, Peelay Z, Chakraborty S, Jadhav M, Alone M, Bhagyavant P, Kolkur M, Srinivas S, Das S, Roy S, Mandal T, Dsouza H, Saha S, Rai R, Srikanth A, Shah D, Khan A, Muthuluri H, Kumar A, Agarwal A, Rajpurohit A, Goli V, Sekar A, Mantri A, Kanteti A, Majumdar S, Khaddar S, Shenoy R, Elamarthi P, Rathnaswamy N, Kashyap L, Abraham G, Booma N, Simha V, Chaukar D, Pai P, Nair S, Laskar S, Nawale K, Naidu P, Salian S, Shelar P, Raulo R, Dhumal S, Prabhash K (2024).Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer. European Journal of Cancer. 200: 113560.
3. McLeod M, Torode J, Leung K, Bhoo-Pathy N, Booth C, Chakowa J, Gralow J, Ilbawi A, Jassem J, Parkes J, Mallafré-Larrosa M, Mutebi M, Pramesh CS, Sengar M, Tsunoda A, Unger-Saldaña K, Vanderpuye V, Yusuf A, Sullivan R, Aggarwal A (2024). Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study. Lancet Oncology. 25(2): e63-e72.
4. Gupta SK, Gohil D, Momin MB, Yadav S, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Hingorani L, Khattry N, Gota V (2024). Withania somnifera extract mitigates experimental acute graft versus host disease without abrogating graft versus leukemia effect. Cell Transplantation. 33: 9636897241226573.
5. Vasundhara P, Nagaraju P (2024). Impact of balanced lifestyles on childhood development: A study at crèche. Journal of Addiction Therapy and Research. 8:1-8.
6. Ranade M, Epari S, Shetty O, Dhanavade S, Chavan S, Sahay A, Sahu A, Shetty P, Moiyadi A, Singh V, Dasgupta A, Chatterjee A, Kannan S, Gupta T (2024). CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization. Journal of Neuro-oncology.
7. Manjali J, Keluskar Geyata, Patel Ruchi, Bano N, Shaikh F, Malhotra R, Mani S, Kumar A, Sinha S, Krishnamurthy R, Dasgupta A, Chatterjee A, Tibdewal A, Pathak R, Mummudi N, Wadasadwala T, Laskar S, Sarin R, Agarwal JP, Gupta T (2024). Validation testing of OUTPATSAT-35RT questionnaire to assess satisfaction in patients on outpatient radiotherapy in a large Indian cohort. Journal of Cancer Research and Therapeutics.
8. Rashid M, Rashid R, Gadewal N, Carethers J, Koi M, Brim H, Ashktarab H (2024). High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer. Neoplasia. 49: 100970.
|
|
|
Interesting Reads
|
Scott MT, Liu W, Mitchell R, Clarke CJ, Kinstrie R, Warren F, Almasoudi H, Stevens T, Dunn K, Pritchard J, Drotar ME, Michie AM, Jørgensen HG, Higgins B, Copland M, Vetrie D. Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease. Nature Communications. 15(1): 651.
|
|
Video of the Week
|
|
Systemic and Local Immune Dynamics in Cancer Immunotherapy |
|
|
|
|
|
|
Do You Know?
In 1975, Köhler and Milstein developed methods for producing antibodies by fusing cultured myeloma cells with normal B cells from immunized mice.
|
|
|
Cancer News
|
|
|
|
|
Study suggests that unintentional weight loss is a signal to see a doctor.
|
Sciencedaily, 23/01/2024
|
The study assessed 157,474 participants in two large longitudinal studies: the Nurses' Health Study, which enrolled nurses aged 30 to 55 starting in 1976, and the Health Professionals Follow-Up Study, which enrolled male health professionals aged 40 to 75 years starting in 1986...
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|